During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky. The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates ...
22hon MSN
Outrage over potentially cancer-curing drug hidden by CIA for years spirals as new patent surfaces
A US patent describing a potential cancer treatment is drawing renewed attention after a CIA document resurfaced describing similar research more than 60 years ago.
Cipla USA has recalled over 400 cartons of Nilotinib Capsules used to treat blood cancers after they failed to meet specifications, according to the U.S. Food and Drug Administration, which classified ...
A US-based subsidiary of drugmaker Cipla is recalling over 400 cartons of generic anti-cancer medication due to a ...
A phase III trial found that combining giredestrant with Pfizer’s Ibrance did not significantly slow disease progression compared with standard ...
Cipla recalls over 400 cartons of Nilotinib cancer medication in the U.S. due to manufacturing specification issues, USFDA reports.
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...
Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an exclusive global licensing deal with ...
Sagar Lonial, MD, discusses the evolving role of cereblon E3 ligase modulators (CELMoDs) in the treatment of multiple myeloma. In an interview with Targeted Oncology, Sagar Lonial, MD, Professor and ...
Discover how India's unique resources could lead to groundbreaking advancements in global cancer care and research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results